-
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) raised $100 million through the sale of 8 million shares at $12.50 in a follow-on underwritten by Jefferies; Cowen; JMP Securities; Needham; Ladenburg Thalmann; Roth Capital …
Published on 5/15/2013
-
Ambit Biosciences Corp. (San Diego, Calif.) amended its IPO and now plans to sell more shares at a lower price. The company plans to sell 8.1 million shares at $8, which would raise $65 million and value the company at…
Published on 5/15/2013
-
Gene therapy company bluebird bio Inc. (Cambridge, Mass.) filed to raise up to $86.3 million in an IPO underwritten by JPMorgan; BofA Merrill Lynch; Cowen; Canaccord; and Wedbush. Late this year, the biotech plans to …
Published on 5/15/2013
-
Cancer immunotherapy company Kite Pharma Inc. (Los Angeles, Calif.) raised $20 million in a series A round. The company also converted $15 million in outstanding promissory notes from Kite's seed round into series A …
Published on 5/15/2013
-
Rockwell Medical Technologies Inc. (NASDAQ:RMTI) raised $35 million through the sale of 11.5 million shares at $3.05 in a follow-on underwritten by Chardan Capital Markets; Summer Street; and C&Co/Prince Ridge. Rockwell…
Published on 5/15/2013
-
Tokai Pharmaceuticals Inc. (Cambridge, Mass.) raised $35.5 million in a series E round from existing investors Apple Tree Partners and Novartis Venture Funds, as well as undisclosed angel investors. Tokai's galeterone …
Published on 5/15/2013
-
Vivus Inc. (NASDAQ:VVUS) said it plans to raise $200 million through the sale of unsecured senior convertible notes due May 1, 2020. The company markets obesity drug Qsymia phentermine/topiramate in the U.S. Last week, …
Published on 5/15/2013
-
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) proposed a follow-on late Tuesday underwritten by Jefferies; Cowen; JMP Securities; and Needham. Acadia plans to submit an NDA to FDA for pimavanserin around the end of next …
Published on 5/14/2013
-
Callidus Biopharma Inc. (Doylestown, Pa.) debuted on Tuesday with $4.6 million in a series A round led by two undisclosed investors, with participation from undisclosed private investors. Callidus is attaching insulin-…
Published on 5/14/2013
-
Esperion Therapeutics Inc. (Plymouth, Mich.) filed to raise up to $70 million in an IPO underwritten by Credit Suisse; Citigroup; JMP Securities; and Nicolaus Weisel. Esperion's ETC-1002 is in two Phase IIa trials to …
Published on 5/14/2013
-
Healthcare VC firm Third Rock Ventures named John Maraganore, CEO of RNAi company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), a venture partner. Third Rock also named Daniel Lynch and Steven Paul as venture partners. …
Published on 5/14/2013
-
Dyax Corp. (NASDAQ:DYAX) proposed to raise about $30 million through the sale of 8.9 million common shares at $2.30 and 41,418 shares of series 1 convertible preferred shares at $230 in a registered direct offering to …
Published on 5/13/2013
-
Shares of Optimer Pharmaceuticals Inc. (NASDAQ:OPTR) jumped $1.85 (14%) to $14.66 on Monday after media reports surfaced that at least three companies made bids to acquire the company. The companies rumored to have made…
Published on 5/13/2013
-
Discovery Laboratories Inc. (NASDAQ:DSCO) raised $14.3 million on Friday through the sale of 9.5 million shares at $1.50 in a follow-on underwritten by Stifel Nicolaus Weisel. Discovery Labs proposed the offering late …
Published on 5/10/2013
-
Optimer Pharmaceuticals Inc. (NASDAQ:OPTR) fell $2.11 (14%) to $12.81 on Friday after reporting 1Q13 financial results late Thursday that missed the Street. The company reported a 1Q13 loss per share of $0.65, wider …
Published on 5/10/2013
-
Sequenom Inc. (NASDAQ:SGNM) gained $0.47 (13%) to $4.04 on Friday after the company reported 1Q13 revenues of $38.5 million, up 158% over $14.9 million in 1Q12. The Street was expecting $38.3 million. Diagnostics …
Published on 5/10/2013
-
Warburg Pincus raised $11.2 billion for its eleventh fund, Warburg Pincus Private Equity XI. Warburg invests in healthcare, energy, financial services, technology, media and telecommunications and consumer, industrial …
Published on 5/10/2013
-
Japanese gene therapy company AnGes MG Inc. (Tokyo:4563) said it hopes to raise at least Y5.1 billion ($51.2 million) through May 19, 2014, through the exercise of 20,000 stock acquisition rights by Merrill Lynch Japan …
Published on 5/9/2013
-
Shares of Dendreon Corp. (NASDAQ:DNDN) slid $0.71 (15%) to $4.03 on Thursday after the company reported 1Q13 net revenues of prostate cancer drug Provenge sipuleucel-T -- the company's sole marketed product -- that …
Published on 5/9/2013
-
Frazier Healthcare raised $281.8 million of a planned $300 million for its seventh fund, Frazier Healthcare VII, according to an SEC filing. Frazier's prior fund closed at $600 million in 2007. The firm is primarily …
Published on 5/9/2013
-
Antisense technology company Isis Pharmaceuticals Inc. (NASDAQ:ISIS) raised $171 million through the sale of 9 million shares at $19 million in a follow-on underwritten by Goldman Sachs; JPMorgan; Stifel Nicolaus Weisel…
Published on 5/9/2013
-
NPS Pharmaceuticals Inc. (NASDAQ:NPSP) reported 1Q13 earnings on Thursday, including $654,000 in the first sales of Gattex teduglutide, which the company launched in the U.S. in February to treat short bowel syndrome (…
Published on 5/9/2013
-
Omeros Corp. (NASDAQ:OMER) proposed late Thursday to raise $16.2 million through the sale of 3.9 million shares at $4.14 in a registered direct offering to RA Capital Management and undisclosed investors. The price is a…
Published on 5/9/2013
-
Receptos Inc. (NASDAQ:RCPT) raised $72.8 million through the sale of 5.2 million shares at $14 in an IPO late Wednesday. Credit Suisse; Leerink; BMO Capital Markets; and Wedbush are underwriters. The price -- at the low…
Published on 5/9/2013
-
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) disclosed in a 10-Q late Tuesday that a modified REMS for narcolepsy drug Xyrem sodium oxybate could include new requirements that could "make it easier for future generic …
Published on 5/8/2013